SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-174335
Filing Date
2024-07-02
Accepted
2024-07-02 16:15:54
Documents
15
Period of Report
2024-07-01
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d775614d8k.htm   iXBRL 8-K 28455
2 EX-10.1 d775614dex101.htm EX-10.1 13913
  Complete submission text file 0001193125-24-174335.txt   204295

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20240701.xsd EX-101.SCH 3217
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alvr-20240701_def.xml EX-101.DEF 13744
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20240701_lab.xml EX-101.LAB 22527
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20240701_pre.xml EX-101.PRE 14560
17 EXTRACTED XBRL INSTANCE DOCUMENT d775614d8k_htm.xml XML 5274
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 241095496
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)